Skip to main navigation
About
Overview
Leadership
Board of Directors
Contact
Pipeline
Overview
CR-001 (PD-1 x VEGF)
CR-002 (PD-L1 ADC)
CR-003 (ITGB6 ADC)
Presentations & Publications
Patients
Commitment
Clinical Trials
Expanded Access
Resources
Investors
Overview
Press Releases
Events & Presentations
Stock Information
Corporate Governance
SEC Filings
Investor Resources
Careers
Culture & values
Benefits
Open Positions
Unsubscribe from all Crescent Biopharma email alerts
Investor FAQs
Email Alerts
Contact IR
Unsubscribe from all Crescent Biopharma email alerts
Email Address
Leave this field blank
Print
Contact IR
Email
